Coronavirus Covid-19 Information

NMIC Bulletin Vol. 21 No. 2 Management of Ulcerative Colitis

9 June, 2015

Management of Ulcerative Colitis

  • Ulcerative Colitis (UC) is a relapsing, remitting inflammatory disease of the colon
  • The aims of treatment are to induce and maintain remission of disease
  • 5-aminosalicylates (with/without corticosteroids) are recommended as first-line treatment of UC
  • Immunomodulatory or biological agents are indicated if first-line treatment fails or is not tolerated